Potential clinically significant drug‐drug interactions of hydroxychloroquine used in the treatment of COVID‐19

Connecting With Patients—The Missing Links

(2020) Lisa Sanders et al.   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

Clinical characteristics and imaging manifestations of the 2019 novel coronavirus disease (COVID-19):A multi-center study in Wenzhou city, Zhejiang, China

(2020) Wenjie Yang et al.   JOURNAL OF INFECTION

Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study

(2020) Nanshan Chen et al.   LANCET

Mechanisms of action of hydroxychloroquine and chloroquine: implications for rheumatology

(2020) Eva Schrezenmeier et al.   Nature Reviews Rheumatology

A Rapid Systematic Review of Clinical Trials Utilizing Chloroquine and Hydroxychloroquine as a Treatment for COVID‐19

(2020) MD Sadakat Chowdhury et al.   ACADEMIC EMERGENCY MEDICINE

Safety considerations with chloroquine, hydroxychloroquine and azithromycin in the management of SARS-CoV-2 infection

(2020) David N. Juurlink   CANADIAN MEDICAL ASSOCIATION JOURNAL

Hydroxychloroquine and azithromycin as a treatment of COVID-19: results of an open-label non-randomized clinical trial

(2020) Philippe Gautret et al.   INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS

Presenting Characteristics, Comorbidities, and Outcomes Among 5700 Patients Hospitalized With COVID-19 in the New York City Area

(2020) Safiya Richardson et al.   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

Baseline Characteristics and Outcomes of 1591 Patients Infected With SARS-CoV-2 Admitted to ICUs of the Lombardy Region, Italy

(2020) Giacomo Grasselli et al.   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

Challenges and cares to promote rational use of chloroquine and hydroxychloroquine in the management of coronavirus disease 2019 (COVID-19) pandemic: a timely review

(2020) Boscolli Barbosa Pereira   JOURNAL OF TOXICOLOGY AND ENVIRONMENTAL HEALTH-PART B-CRITICAL REVIEWS

Hydroxychloroquine prophylaxis for COVID-19 contacts in India

(2020) Sahaj Rathi et al.   LANCET INFECTIOUS DISEASES

Hydroxychloroquine in the management of critically ill patients with COVID-19: the need for an evidence base

(2020) Fabio S Taccone et al.   Lancet Respiratory Medicine

Risk of QT Interval Prolongation Associated With Use of Hydroxychloroquine With or Without Concomitant Azithromycin Among Hospitalized Patients Testing Positive for Coronavirus Disease 2019 (COVID-19)

(2020) Nicholas J. Mercuro et al.   JAMA Cardiology

Assessment of QT Intervals in a Case Series of Patients With Coronavirus Disease 2019 (COVID-19) Infection Treated With Hydroxychloroquine Alone or in Combination With Azithromycin in an Intensive Care Unit

(2020) Francis Bessière et al.   JAMA Cardiology

Hydroxychloroquine and COVID-19: critiquing the impact of disease public profile on policy and clinical decision-making

(2020) Yves S J Aquino et al.   JOURNAL OF MEDICAL ETHICS

COVID-19 prevention and treatment: A critical analysis of chloroquine and hydroxychloroquine clinical pharmacology

(2020) Nicholas J. White et al.   PLOS MEDICINE

Prescriber response to computerized drug alerts for electronic prescriptions among hospitalized patients

(2017) Yael Zenziper Straichman et al.   INTERNATIONAL JOURNAL OF MEDICAL INFORMATICS

Medication-related clinical decision support alert overrides in inpatients

(2017) Karen C Nanji et al.   JOURNAL OF THE AMERICAN MEDICAL INFORMATICS ASSOCIATION

Variation in high-priority drug-drug interaction alerts across institutions and electronic health records

(2016) Dustin S McEvoy et al.   JOURNAL OF THE AMERICAN MEDICAL INFORMATICS ASSOCIATION

Prevalence and Risk of Potential Cytochrome P450–Mediated Drug-Drug Interactions in Older Hospitalized Patients with Polypharmacy

(2013) Julie Doan et al.   ANNALS OF PHARMACOTHERAPY